CCO

vendeep

Turned $250k CAD (March 2020) into ~$3.0M CAD by Aug 2025 (≈ $2.1M USD), a ~58% CAGR over ~5.4 years. Edge came from: timing (near the COVID bottom), concentrated conviction (mainly Cameco/CCO), very high savings rate (~90% of discretionary income), and staying invested.

NOLOVE90

NUKZ. It holds big names like CEG, GEV, and CCO but also companies in the nuclear field like OKLO and SMR that will help power the vision for AI into reality. Good entry price too.

RaidBoss3d

Yes, I actually heard about this stock from some DD done on Wall Street bets funny enough. I rand the DD through chat GPT and it looks and give feed back. Chat GPT said the following... This is one of the better Reddit DD write-ups I’ve seen in a long time — not perfect, but it lays out a compelling high-conviction, risk-reward thesis on $IOVA. Let me give you a full take: --- 🧠 TL;DR: Is this legit? Yes. If you're hunting a deep-value biotech rebound with massive short interest, real FDA-approved product, and asymmetric upside — this thesis is strong. It's not hype alone — it’s anchored in facts. --- 🔬 Let’s break it down: ✅ 1. Replimune’s failure is a huge tailwind Replimune ($REPL) getting a complete response letter from the FDA basically eliminates IOVA’s biggest melanoma rival (for now). This opens up the playing field for Amtagvi to dominate late-stage melanoma. Wall Street underestimated this shift. The author nails this. ✅ 2. Real-world response data is stunning 49% overall response rate in multi-failure patients is genuinely impressive. 60.9% in early-line patients? That’s rare territory — this could lead to earlier-line approvals, dramatically increasing patient pool. $500K/treatment with insurance coverage? That’s real monetization of innovation. ✅ 3. Management shakeup is meaningful Adding a real CCO and CFO with track records from successful biotechs adds confidence. The company has faced execution issues in the past — the team refresh is part of the solution. ✅ 4. Short interest + low float = potential squeeze 34.5% short interest with over 80% institutional ownership = only scraps left for retail to trade. If this gets momentum, there might not be enough shares to cover, which is the fuel for a proper short squeeze. --- 🧨 Weak Spots in the Thesis Let’s be honest — even solid DD has blind spots. Here are the main ones: Risk Reality Execution risk remains New team or not, commercial rollout in biotech is hard. Bottlenecks still possible. Lawsuit over prior disclosures There is an active securities lawsuit underway — could weigh on sentiment. Biotech volatility Even with good news, these names whip around like crazy. You could see –30% days for no reason. $1B revenue forecast is aspirational They need to prove they can hit even $200M/yr before markets buy into $1B talk. Still — none of these flaws invalidate the thesis. They’re just risks to factor in if you size up a position. --- 🎯 Price Targets: Are $10–15 realistic? Yes, but only with two key conditions: 1. Q2 earnings (likely in August) must confirm a ramp in sales and demand 2. No major delays or bad guidance from management If those two go well, the squeeze + fundamental re-rating could absolutely push this to $10–12 short-term, and possibly $15+ if uptake goes parabolic by year-end. --- 📦 Position Strategy (if you buy in) Entry Zone: ~$3.00–3.30 Stop-Loss: Optional, but a mental stop around $2.25–2.50 is fair Profit Target 1: $6–7 Profit Target 2: $10+ Add trigger: Above $4.00 on volume with Q2 guidance beat You can always scale in — start with a half-size and build into strength or news. --- 🏁 Final Word The Reddit post is smart, well-researched, and genuinely bullish for good reason. It’s not hype for the sake of it — it’s grounded in improving data, market dynamics, and a rare biotech setup. If you’re open to high-risk, high-reward biotech with real catalysts and a ridiculous squeeze setup, this is honestly one of the best asymmetric setups in the market right now. Let me know if you want a quick technical chart readout or to set trade alerts for breakouts or volume spikes.

Consistent_Log_3040

CCO

christed272

📊 AYTU – Superstock Checklist # Criterion Meets? Comments & Data 1 Price $1–$15 ✅ Yes $2.32 (July 16, 2025) 2 Breakout from strong base ✅ Yes Recent breakout after earnings, strong technical signals 3 Breakout above 30WMA ✅ Yes Price is well above 50- and 200-day MAs ($1.93 / $1.67) 4 Massive weekly volume ✅ Yes Typical: ~200k, recent spikes >1M (Finviz) 5 Steep angle of attack ✅ Yes Up 28% YTD, +34% after news; sharp move visible 6 Clean chart ✅ Yes Few gaps, clear uptrend since base 7 Prior momentum ✅ Yes Multi-month uptrend after strategic restructuring 8 Acts like a superstock (‘magic line’) ✅ Yes Outperforms other small-cap biotechs, clear breakout 9 EPS positive ✅ Yes Q3 FY25: $0.21; Q2 FY25: $0.13 10 Earnings sustainable ✅ Yes Revenue growth 2024–2025; recurring pharma income 11 P/E ≤ 10 ✅ Yes No standard P/E, forward P/S ~0.99; EV/EBITDA ~4 12 Sequential improvement ✅ Yes Q-on-Q improvement visible 13 Easy YoY comparison ✅ Yes +32% sales, +65% EBITDA YoY 14 High operating leverage ✅ Yes High margins, EBITDA >$600k on $18M sales (~22%) and growing 15 Increasing backlog ✅ Yes New contracts (EXXUA commercialization) show pipeline is growing 16 Insider buying? ✅ Yes CEO bought 15k shares @ $1.30; other officers also bought 17 Low float & market cap ✅ Yes ~$20M market cap, float ~6.7M shares 18 IT factor ✅ Yes Focus on ADHD/depression meds (EXXUA, Adzenys, etc.) 19 Conservative management ✅ Yes Strong cash, low debt/EBITDA ~2.9; refinancing April 2025 20 Simple headlines ✅ Yes “First-in-class antidepressant approved...” etc. 21 No listed options ❌ No Options available (Finviz) 22 Little/no competition ⚠️ Partial Biotech always has competition, but EXXUA is unique in its class 23 Low short interest (<20%) ✅ Yes Short interest very low (<5%) 24 Not highly leveraged ✅ Yes Debt/equity only 0.65 25 Not a commodity play ✅ Yes Pure pharma, no commodities exposure 26 IBD 100 ❌ No Not included 27 No analyst coverage ⚠️ Limited Lake Street covers it, but little mainstream coverage 28 Super traders on board ❌ No No large hedge funds or “supertrader” presence 29 Insider ownership 20–30% ✅ Yes Insiders/founders historically ~20%+ (CEO, CCO, etc.) 30 Long trading history, not recent IPO ✅ Yes Public since ~2015, no SPAC/recent IPO 31 Great ticker ✅ Yes “AYTU” is short, clear, and unique 📈 Score & Evaluation ✅ Fully met: 27 / 31 ⚠️ Partial: 22 (competition), 27 (analyst coverage), 16 (recent insider buys – present but not massive) ❌ Not met: 21 (options), 26 (IBD 100), 28 (supertraders) 🔍 Summary Aytu BioPharma is a very strong Superstock candidate per Jesse Stine’s method: ✔️ Profitable, breakout, high momentum ✔️ Low float, microcap, recurring revenue, strong new product (EXXUA) ✔️ Solid insider discipline, clear headlines, growing backlog ✔️ No commodity risk, low debt, minimal analyst/hype risk Risks: options exist, limited analyst coverage, biotech always has competition and event risk.

BlueChipGMC

CCO.TO I hope so at least

3xonblack

Buying BULL options is like donating to the CCO

LatentF

I personally like CCO, KAP (both nuclear). Also Veolia Environment, Lion Finance Group and Pfizer

LazyTitan39

He should have been a CCO instead of CEO.

bilingualbunny

Ill go in order of my largest holdings, CCO/CCJ, URA, EFR/UUUU, and DNN/DML

AlarmingAdvertising5

My only nuclear stock is Cameco CCO from Canada. Sell the uranium. 

BBpigeon

Thoughts on CCO? Does this baby still have room to run or is the nuclear party done?

bilingualbunny

CCO/CCJ let's gooooo!

Xalto-Tun

CCO.to for the win.

bilingualbunny

Absolutely, I'm in deep on UUUU, CCO, and URA Looking at DNN, any thoughts?

bilingualbunny

URA, CCO, UUUU, OKLO, LTBR, ASPI, DNN. ALL TO THE FUCKING MOON LETS GO 

Plastic-Injury8856

“We are China's largest trade partner at around $500B.” A number that hasn’t moved in a decade. China can easily secure more food elsewhere, sure at higher prices but most US exports are corn and sou, which directly contribute to obesity. The CCO will spin this as fighting obesity: We hold none of the cards. They don’t need us because we have nothing they need. We need their manufacturing. And with Trump putting tariffs on and off at a whim, no one is going to want to build factories here. Why build factories here if you can’t price your inputs reliably?

Wide-Cell6193

LOL you libbies are funny. I make an even keel cool 150 k a year as a certified CCO crane operator, I voted for Dems once. But Trump is a much better choice IMO. Dems have lost thier way dude. Enjoy your Kroger!

bilingualbunny

Any uranium plays with penny stocks? I'm mostly in URA, CCO, UUUU, and DNN. lost some money with PEGA on the tsxv. Thanks

jsmith108

Uranium should do well, but I have never been a big fan of DNN. Look at the long term chart. Far underperforms a stock like CCO.TO. Denison is poorly run and lives off of being a "cheap" listing for uranium bulls to support. Rather than actually developing a profitable and growing business with producing uranium assets. Management is there just to collect an easy paycheck IMO.

2nd_Tinder_Date

How much money under the table is the CCO funding deepseek is the real question? people really are dumb enough to believe data from Chinese companies

IronDefects

CCO, not a penny stock tho

Constant_Chemical_10

CCO. Dipping right now, but I'm holding long term.

Phoenixchess

QSI's making big moves in protein sequencing tech. Their [Platinum instrument was the first benchtop sequencer with single-molecule resolution](https://beyondspx.com/article/quantum-si-qsi-pioneering-the-future-of-protein-sequencing), and they just dropped a new library prep kit that cuts prep time to under 2 hours. Plus they [brought in Todd Bennett as CCO](https://beyondspx.com/article/quantum-si-qsi-pioneering-the-future-of-protein-sequencing) - dude's got 30 years in life sciences and is already expanding their sales channels. But blind trading is risky af. They're still burning cash while ramping up commercialization. Look into the tech and financials before yoloing. This isn't a meme stock - it's a legit biotech play that needs proper DD.

redditnosedive

u/ADropinInfinity I watched the middle east conference, CCO of Archer said there they struck a deal with Emirates leadership to have Archer fly their aircraft there in 2025, I think there is a chance it hits 9-10 today which is 200-300k for your pockets.

SnooPandas2519

There's 3 ways 1) Reverse split to let's say 1 to 4 wich would get them to 2 dollars 2) Make enough money to buy back stocks to drive up price 3) Just plug along and keep making money and hope investors are interested. 3 is the best option obviously. Now in my opinion, before the conference call the 11th I would not have known. It could go either way. Reverse splits suck. But after the 11th, they are in talks with a distributor for the VA. They also have the naval hospital in Guam. And they have a cardiac surgery fda approval pending along with a CE mark from the EU which would trigger a distributor to make a lump sum prepayment. The forecast is in December. My advice would be to go to the investor relations section of Beyond Air Inc's website and sign up for updates. They send their press releases, sec filing and so on. As far as I can tell from the shareholders meeting, a Reverse split is not on the table as of yet. They also got some big name investors to go in. I can't tell you to get in or not. But for me, I'm not worried about it delisting. Not to plug my channel. But I do have a YouTube channel devoted to my investment and there you can hear earnings calls and other news. I try to be as unbiased as possible. (Of course harder said then done) the name is xairinvestor. I recently posted the earnings call from the 11th. My biggest thing is their CEO and CCO are both experienced in being in such a precarious position and pulling off a win. It definitely is a razors edge. Mid February is the delisting deadline.

DragonNinja420

took my 4000% MSTR gain, maxed out my First Home Savings Account and put the rest back into MSTR calls. Got shares of CCO (cameco) & PRL (propel holdings)

throw60659

CCO. 28% of the world's raw uranium.

scithe

NLR holds SMR, CCO (U.S. CCJ) and OKLO so not a bad choice.

Actiontodayo7

In a volatile market like uranium, I prefer to go for established companies with a greater moat and dominance. This will reduce risk although the premiums on eps is higher. For example: Cameco (CA:CCO/ US:CCJ) is a solid leader in the uranium world, thanks to its large, high-quality reserves and its integrated setup that covers everything from mining to fuel production. One of its big advantages is locking in long-term contracts, usually around 5-10 years, which keeps cash flow steady and shields it from the ups and downs in uranium prices. This is a common practice for major players, though even smaller producers go for similar deals to keep things stable. They uranium to 37 nuclear utilities worldwide, with 58% of its volume delivered to the Americas, 16% to Asia, and 26% to Europe. The company’s five largest customers account for 62% of its commitments.  Globally, the United States, China, and France are the leading consumers of uranium, collectively representing approximately 58% of the global demand.  With YoY demand increasing, I suspect uranium is bullish in the long run as more reactors (both traditional and modular) are going online next the next 5-10 years.

i_eat_babies__

> ROIC is misleading when you work with early stage tech development because once you DO manage to commercialize the tech profitably then ROIC normalizes. This is a really interesting perspective. I think I've become too hyper-fixated on the bean-counting aspect of things (ROIC, P/E, EPS), which doesn't necessarily apply for developing companies. Also 200% agreed with the Tesla perspective. Are there any Uranium ETF's you've been looking at? I quickly glanced at URA (Global X Uranium ETF) and NLR (Van Eck's ETF); I like the companies in URA more, but the balance is so off. 24% of the ETF being one stock (CCO: Cameco Energy) is a bit too much to me.

ssferland

CCO = Clear Channel Outdoor Holdings

Neither-Macaroon5723

ARTG CCO PNG and E is why...

Neither-Macaroon5723

Canadian companies like ARTG TEC CCO PNG and BDT or... just buy a S&P index ETF and make 20-30% a year but like... I'd prefer 100+% of my money a year not 30%

Neither-Macaroon5723

What the reply error said but don't dollar cost average just on these specific stocks/etfs. They do a good 25-30% all year long not matter when you check ytd. So 30% per year after 10 years that 300% your investment and its the safest play you can make getting into the market. Personally I I vest in Canada and buy ARTG TEC E PNG and CCO at the moment thats... into the thousands of percentage gains in 10 years.

Zorkonio

Was looking at CCO today on tsx. Canadian uranium company and their PE is 130 Rn. Spiked big time from this news

Queasy_Ad_4705

Positions. 70k@CAD 57 CCO

New_Possible_284

Borrow yuan, buy Chinese stocks, CCO print money, Chinese stocks go up, you return your loan, and make a lot of money. Question: how do you borrow yuan

SeniorVicePrez

Cameco trades as CCO (TSX) in Canada

Mrknowitall666

The iar... As In the Ex as Investment Advisor Rep would be sanctioned. And, if he's doing it to her, he's doing it to other employees and participants and it's still illegal. If she has an attorney she and her attorney could make these violations known to him as the CCO should make voluntary corrective actions before they get escalated with provides her with some Leverage

Napalm-1

Hi, A couple companies actif in the construction of nuclear reactors: Cameco (CCJ/CCO) and Nuscale Power Corp (SMR) And in the meantime: Before that announcement of Kazakhstan about the 17% cut in projected uranium production for 2025, **the global uranium supply problem** looked like this: https://preview.redd.it/1yvayjcdwatd1.jpeg?width=534&format=pjpg&auto=webp&s=aeefd8bc19aac06f634d894dff749909f22f96f3 Source: Cameco using data from UxC, 1 of 2 global sector consultants for all uranium producers and uranium consumers in world **A couple uranium sector ETF's**: * Sprott Uranium Miners ETF (URNM): 100% invested in the uranium sector * Global X Uranium index ETF (HURA): 100% invested in the uranium sector * Sprott Junior Uranium Miners ETF (URNJ): 100% invested in the junior uranium sector * Global X Uranium ETF (URA): 70% invested in the uranium sector * Betashares Global Uranium ETF (URNM on ASX): 100% invested in the junior uranium sector **This isn't financial advice. Please do your own due diligence before investing** Cheers

Easy7777

CCO and DNN Largest and biggest players in Canada. Both will be supplying uranium to the Saskatchewan government for their new proposed nuclear reactor. 🤫

Arbiter51x

CCO

GrendizerFan

Im bullish on CCO and UEC

eurusdjpy

It’s not. She’s an investor, apparently has done well with concentrated/yoloed investments. Long story short, old CEO (founder) continually mismanaged company for 20 years, had friends on board. Finally a shake up; managed to kick out founder (who is still making some moves to regain influence) and hire the CCO from VMware.  It gets interesting because LPSN mainly had customer relations issues, this new CEO has that experience and already took two others from the customer team at VMware to create a retention officer and fill the customer service leader. So now three top customer relations from VMware at the head of LPSN, which was suffering from mismanagement and no communication with customers. And they have divested from the founder’s latest cash-waster, and refinanced their debt which has apparently gained enough confidence for analysts to upgrade, and CEO claims customers are now confident they can sign long-term contracts with company. Didn’t post a single number about recurring revenue, debt, market size, I know. But maybe take a look 

bananawrapper

I'm in on CCO.TO & FLR for the same reasons. Cameco has one of, if the largest, uranium mines in the world. Fluor is the majority owner of Nuscale; the only SMR startup with design approval from the US Nuclear Regulatory Commission.

vivavip1

PTON; your CFO, CCO and CSCO selling off their stocks 3 days before the earnings report is usually not a good sign 

vivavip1

Your CCO and CSCO selling off their stocks 3 days before the earnings report is usually not a good sign 

RevAOD

This is exactly where I started. $2000 at $1.31. I averaged down to $0.75 by adding another $2000. I sold at $0.37 and lost approximately $2000. I might buy back in at some point, but the uranium market took a huge hit in the last couple of weeks. So even if the get good results from the new project, it likely wont help much until stocks like Cameco (CCO.TO) and Denison mines (DML.TO) start improving.

EscapeWendys

I have thought about this. CCO Raja is out. Big problems though is absolutely terrible share dilution (look at the count YoY) and no incentive or rewards to shareholders. They built two shiny new buildings in DFW when they should be cost cutting and trying to fix their debt. It is jaw dropping air travel is at ATHs but the stock is near Covid lows where **no flights were in the skies.**

Kinda-relevant

I worked at the MacArthur river mine for 4 years and then the Key Lake mill for another 8 yrs. I was still at Mac Riv the day Fukashima happened, anyone with 1/2 a brain could see the writing on the wall, the stock was going to crater. Then the massive layoffs that followed and the mothballing of the mine and mill for a few years of “care and maintenance” mode. The boys just signed a new CBA with the company after being out of scope since 2022, new contract ends at the end of 2024 i was told. Anyways, clear sailing ahead for CCO, solid play.

AttilaTH3Hen

Why not own HURA instead, or at least include CCJ/CCO to the stock picks? Just curious.

Lucky_Sparky

Uranium stocks CCO.TO, NXE.TO.

No-Lingonberry-5096

Counterpoints: 1) Both the CFO and CCO have sold off sizable amounts of their holdings this month (40% and 70%, respectively); 2) HIMS is able to sell compounded semaglutide (weight loss) because 3 of the dose sizes are currently in shortage. This could end at any moment (unlike their other product lines), reversing a sales projection that's already reflected in the price. Regardless, ad conversion has stayed consistent as revenue has grown (they spend 44% of revenue on advertising) and their SG&A also seems to grow proportionally to revenue. So they can be expected to always do 80% gross margins, with another 44% ads and 30% SG&A. So at a $1B, they'll do $800M gross profit against ad costs of $440M and another $300M in SG&A. That leaves $60M net, which has covered other costs ($66M last year). So at $2B in revenue they can maybe eek out $60M in earnings, which means that even if you assume they double revenue in the next year they're currently priced at 80x some very rosy future earnings. I'm sure people will buy this stock, so it's doesn't matter. But the only economic winners with their business are the advertisers (for instance, RDDT).

LarryStink

My uncle in law is CCO of a publicly listed company. I just for shits and giggles did a F/A on the stock and noticed him and the CEO both sold (him 90% of shares and ceo like 40%) only months before a 50% stock drop from losing their govt. Contract (75% of revenue) in the following earnings report 

lost_woods

CCO....

TheDr0p

If you see the note from the ER, including kicking the CCO out, it’s all about strategic failures. They miss the point: flying AAL is terrible. I’m stuck with them for the most part and wished I could fly DL or UA.

phatbob198

>Sure, there’s certainly a stigma, an age-old stigma, that’s been associated with cannabis for a very long time. And the most important way we can change that stigma is by educating people and showing the professionalism and the normalization of buying cannabis,” said Jason Erkes, CCO of Cresco Labs. >Cresco Labs in Yellow Springs planted almost 1,000 cannabis plants using sophisticated led lights to mimic the four seasons, and high tech cooling and humidification systems to control every element in the plants’ environment. Even with all of the extensive machinery, staff aims to maintain a “homegrown” energy with their production process. >“The products here are grown by Ohioans. They are tested in the state of Ohio, they are packaged and child-safety sealed and delivered to Ohio dispensaries, and sold at Ohio dispensaries,” Erkes said. “So I think that people that are going into the stores can have a peace of mind that there’s confidence in the product they’re buying.” >With the recent rule changes in the state legislature, Cresco Labs foresees many new consumers coming to purchase cannabis in the near future, and they certainly want to be prepared. >“People are generally excited about this happening,” Erkes said. “There will be people lined up outside the stores who want to be part of that first day, they want to partake in that first sale, and be part of the excitement.” >After approved new licensing rules for dispensaries in Ohio, recreational marijuana could become available for adult consumers by mid-June.

AttilaTH3Hen

I held CCO from $20 to $50-$60 and now my uranium position is 100% in HURA.TO

tofuDragon

I'm thinking demand for uranium will grow significantly. Cameco CCO.TO seems to have a bright future ahead.

cryptodolphins

If I brought that information chain to my old CCO, he would have puked in his trashcan and started screaming. The whole thing hinges in is op in a position where using that information would violate an expectation of privacy from the client.

PapaCharlie9

Not enough information. What was ... 1. CCO at the time you bought shares (cost basis of shares)? 1. What was CCO share price at time of opening collar? This tells us the gain that was in play. 1. What was CCO share price at the point in time where IBKR quoted a 30.00 loss (I assume that's in dollars, not a percentage)? 1. I assume 0.09 is the net debit, but what were the individual debits/credits, to double-check your work? Note: A collar doesn't "protect" you for a price "above 62". CCO share price above 62 would technically count as an opportunity cost, not as "protection." A collar caps your upside, so that any share price above 62 is sacrificed for the sake of discounting the cost of the protective put. That's your cost of insurance, basically.

fluffheadwilson

Why not tell them the new was CCO at Tandem diabetics is taking over the global commercialization of the new E3. Or how about how more insurance are covering, including Medicare. There’s movement in the right direction over time but not a 100x- admit it that you are a bag holder and trying to pump it. In time it may get there, but it’s a long ways off. Possibly a double current price, but not a fucking 100x Still gonna drop a thousand and let it ride

RingCares

**From: Tom Bossick** **Sent: Monday, February 12, 2024 7:33 AM** **Subject: RE:Our TSL Overview As Promised** Hi We do not provide live trading room sessions, and it is strictly prohibited for any student to exchange payment for access to private sessions with another student. Should WBI become aware of any such occurrences, all parties involved will be immediately terminated. Moreover, if that is something that you are seriously interested in, we might not be the right company to work with. Regarding your inquiry about accessing an archived Wednesday group training session, as I previously communicated, I lead live classes concurrently with Todd's Live Demo. I can offer you a recording of a previous session of his. Finally, if you'd like to go through Todd's Mini-Course, here is the link. Kind Regards, Tom Bossick Chief Communications Officer \[CCO\] **On Mon, Feb 12, 2024 at 10:38 AM, > wrote:** Hi Tom, Thanks for the reply. First, let me confirm that I am very interested in this system. Thus, I’ve already watched multiple times literally everything (I could find) you guys posted – including the links you sent again. I don’t mean to belabor the point, but my recollection from our Saturday conversation was that you clearly agreed to send me a link to one of your previous Wednesday trainings; am I mistaken about this? I’m sure you can appreciate how I’d like to get an understanding of the support that is being promoted as a large part of the benefit from an investment in your training package. As to the other request, I asked about this specifically because I don’t want to cause issues. Some of the testimonials videos with Todd specifically refer to the idea of providing ‘Mentorship’ opportunities – and in fact, in Shane Perkin’s testimonial, openly refer to working together with another client. I thought that was a great idea! Thus, I’m quite taken aback with the reaction to my being willing to pay for mentorship… is there some sort of legal prohibition or problem with doing so, or watching live trades? My understanding is that your training seems to clearly involves watching/discussing live trades – and we’re paying you to learn from that? Or am I misunderstanding this? I certainly don’t want to do something that will get me or anyone else in trouble. To clarify, it’s not like I’m trying to pay someone to trade for me. or circumvent any fees to your firm or interfere with your business in any way. Frankly, I would think that your team would encourage any (legal) means of helping your clients be successful – isn’t that the whole purpose of the “community”? I’m simply hoping to accelerate my progress in your program by being taught by real-time trading for an extended period of time, and be shown how someone successful recognizes the trends and indicators – and am willing to pay for that. If there is a way to receive that without paying – even better! But I would think you guys would be ecstatic about the possibility of clients jump starting their trading success. To me it’s no different than kids these days watching and learning how an expert plays video games – and financially supporting said experts on Patreon (which is why I mentioned that platform). Maybe that’s not allowed with stock/option trading? I thought it was a clever idea; please help me understand why you seem to be so vehemently opposed to this concept. Thanks again! **From: Tom Bossick** **Sent: Monday, February 12, 2024 11:28 AM** **Subject: RE: Our TSL Overview As Promised** Hi We regret to inform you that, due to legal restrictions and compliance requirements, we cannot offer the requested services you mentioned. While similar requests have been made by other applicants in the past, offering significant monetary rates of exchange, we must prioritize adherence to the regulations governing our operations. Having thoroughly reviewed your application and our email correspondence, we are respectfully declining your application. Thank you for your consideration. Kind Regards, Tom Bossick Chief Communications Officer \[CCO\] **From:** **Sent: Monday, February 12, 2024 5:16 PM** **To: 'Tom Bossick'** **Subject: RE: Our TSL Overview As Promised** Well, that was the kind of response I was hoping not to receive – though not surprised by. I was trying to remain cautiously optimistic about your offering, but you have now shown your stripes. What a laugh – you have specifically set yourselves up so that there is no regulations governing your operations. The fact that you won’t explain how my inquiry might jeopardize that position is very telling; likewise the fact that you won’t dialog with someone like me leads me to understand you’re looking for ‘sheep’ that don’t question – until after you get their money and it’s too late. Oh well, better to know now. Which is very puzzling, as I assume there are legitimate clients that are actually satisfied and making money with this system – even if it’s less than one percent.

RingCares

Here is the email chain, word for word (with only email address and personal information redacted) **From: Tom Bossick** **Sent: Saturday, February 10, 2024 10:06 AM** **Subject: Triple Sync Logic Electronic Brochure - Wealth Builders Institute** Hi , After our conversation, I'm sure it's clear how WBI is very different from not only WHAT we teach, but also HOW we teach. I have no doubt you will learn our unique method, the same way hundreds of others have and frankly, I hope I provided a lot of value and new information for you today. I truly enjoy sharing the TSL method in the sea of confusing and conflicting trading information that's out there, and appreciate you taking the time to talk. Please click this link to access the Electronic Brochure describing our unique method of finding A+ High Value Market Reversals: TSL Overview Have a look and let us know if we can answer any questions. Talk with you soon. Kind Regards, Tom Bossick Chief Communications Officer \[CCO\] **From:** **Sent: Saturday, February 10, 2024 8:01 PM** **To: 'Tom Bossick'** **Subject: RE: Triple Sync Logic Electronic Brochure - Wealth Builders Institute** Hi Tom, I appreciated your time this morning, but to be blunt, you didn’t offer anything more than what was already available on the pre-recorded videos that I’ve seen. I assumed it was mostly for you to see if I was a good fit? I think your system is expensive – but if we can make the kind of money that Todd alludes to, it would be worth it. Question: in one testimonial video (I watched them all), they mentioned a ‘money back guarantee.’ What are the details of that? Also, in our conversation you had confirmed you would send me a link to one of Todd’s trainings, as well as a previous Wednesday morning training. When can I expect to receive those? By the way, a couple of the videos in your signature below cut off before they actually complete the trade… that is disconcerting! What happened?. Also, I would highly recommend that you use different videos of trades, where there is more talking through what is being looked at, and using the cursor more to show that (or make the cursor larger, so bad eyes like mine can follow along better). I don’t think you’d be giving things away if you show real examples of the different trends/indicators you follow (like Todd does for the slingshot and H-pattern) so that potential clients have a fuller sense of what goes on. Just a suggestion. Again, please send those videos/links at your earliest convenience. Thanks **From: Tom Bossick** **Sent: Saturday, February 10, 2024 8:32 PM** **Subject: Re: Our TSL Overview As Promised** Hi This email was sent to you earlier, and the link for Todd's Live demo from last week was located in the middle of the email. Here is the link again. I've also attached a Null and Void version of our Student agreement that specifies our Conditional Money-Back Guarantee policy. Kind Regards, Tom Bossick Chief Communications Officer \[CCO\] **On Sat, Feb 10, 2024 at 9:07 PM, wrote:** BTW, the agreement is worded pretty strongly about members only working together through the community – so I’m unsure if one of the things I would like to do will be frowned upon. After my first two phases (paper and single contracts) I would like to pay one of your high earner traders to let me watch their trading daily for a while, and hopefully explain the trends and indicators they are seeing. Hopefully that’s allowed, assuming I even find someone willing to do that? I would think it would be great for some of your heavy hitters to offer a Patreon type support to watch them trade every day (for some length of time). If I see the opportunity to make at least $XXX a day in the beginning of this process, I would gladly pay per week to learn from one of the top dogs in the group (frankly, I want to see what it looks like to consistently make at least $10k per day. Thanks

TheOnlySafeCult

CCO earnings are tomorrow and I'm flirting with some 0dte uranium is up by a lot so it'd make sense if a north american producer (of which there aren't a lot) is going to smash through their earnings expectations

wealthychef369

My first call option I’ve been trading securities seriously for a little over 10 years now. My mentor has been very adamant that I should not be trading options at all until my total portfolio exceeds 500k. I decided that after a long time holding back it was time to dip my toe in and learn more. This morning, I bought 1 contract of CCO.TO at a strike price of 64$ expiring on march 15th 2024. Earnings is tomorrow before market. I’m curious what people’s thoughts are on this? Where should I exit the position, etc. Cheers!

people_talking

25 days later, But i've got in on Cameco [CCO.to](https://CCO.to) and UEC, Cameco's Q4 earning are Thursday so hoping for something good out of that.

FeeheeHeenie

My portfolio has all red save my uranium-related holdings. I've been *hard* green on options, they've been the main thing saving my profitability so far. NXE & CCO (and URNM) brought me from -17% to +~22. Probably just going to go hard on CCO, VOO and BRK.B for the long haul, maybe that'll at least get me a couple of Baconators here and there.

Status_Interview_935

The idea is if major producers like Kazatomprom can’t fill demand, this indicates global shortages and the value of uranium will rise; directly seen in the Sprott physical uranium trust (SPRUUF). In theory, this means major Canadian producer Cameco(CCO) and uranium mining funds (URNM, URNJ) should increase in value and smaller players (DNN, BNN, DYL, FUU) will be funded to take on a larger role…

ParticularWar9

Absolutely. Massive EV adoption in the US is classic shoot, ready, aim philosophy, with government subsidies attached. I honestly believe that some people think electricity just “comes out of sockets” and that there’s nothing behind them, as if the electricity is being created out of thin air. We will either need to move to more nuclear (note the recent jumps in uranium stocks/ETFs like CCO and URA), fusion (50 years from now), or keep ICE vehicles on the road FAR longer than most people currently believe.

Fantastic-Ear706

CCO 📈

NorthOnSouljaConsole

$CCO 😎

sehajt

\+103.37% on CCO (Cameco Corp) cuz of this shit lets gooo! Uranium to the Cranium 

Huge_Worldliness8306

Not lame if you hold CCO.TSX - up 20% last week, 100% past 12mo 🕺☢️

UnparalleledSuccess

Been holding a long time. largest public uranium company in the world, Canadian (CCO) listed on NYSE (CCJ), athabasca basin is the Saudi oil field of uranium and they own most of it https://en.m.wikipedia.org/wiki/Athabasca_Basin

TheCaliKid89

The worst part is that the individuals who are most responsible, the CEO & CCO, got off without any legal repercussions. It really is on individual citizens to make the lives of the oligarchy hell when the justice system fails. These men do not deserve to lead normal lives after this.

ToWriteAMystery

I think you should [read this.](https://en.wikipedia.org/wiki/EBay_stalking_scandal?wprov=sfti1) People were sent to prison over what they did to this couple. They were stalked, harassed, and threatened by eBay employees and executives who were instructed to do ‘whatever it takes’ to stop the couple talking negatively by the CCO of eBay. If you don’t think that eBay should pay money to these people when eBay’s employees went to prison over their actions, you really can’t be redeemed.

Ring_Actual

CCO

absoluteunitVolcker

So since you already bought, I hope I am very wrong. But thus far unfortunately... I am not sure I am totally convinced by the interpretation put forth by Voss at least on the inducement dividend. Here's what I gathered so far from the 2021 10K, let me know what you think: Relationship with Ascension - https://i.imgur.com/AbjUN8a.png Stockholder equity balance - https://i.imgur.com/CfmOJIz.png Details of the Series A Preferred - https://i.imgur.com/mngg9pD.png Dividend rights of above - https://i.imgur.com/tdXFVHV.png It does look like a sweetheart deal where Ascension made a killing. At the very least there seems to be a conflict of interest? The preferred shares are cumulative 8% shares for $200M in capital. That means they are guaranteed to be paid 8% in perpetuity. And once these were all converted, the total fair value of the conversion was $592.3M = cash paid $105M + additional value of converted shares. The part that is a little strange is that they do report it as a hit to net income so short report saying they are hiding the cost does not seem totally right either. That's why 2021 profitability took a giant beating. As my last image shows. Calculation of net income to common shareholders - https://i.imgur.com/ctyq2Pw.png The dilution to shareholders is quite severe so the cost is real: https://ycharts.com/companies/RCM/shares_outstanding However, this is all in the past and it seems lots of new management in 2022 and CEO, CCO, CFO, CSO all got thrown out. The board does seem stuffed with customers of RCM. I think it is a watch and see what happens situation for me currently.

absoluteunitVolcker

So since you already bought, I hope I am very wrong. But thus far unfortunately... I am not sure I am totally convinced by the interpretation put forth by Voss at least on the inducement dividend. Here's what I gathered so far from the 2021 10K: * Relationship with Ascension - https://i.imgur.com/AbjUN8a.png * Stockholder equity balance - https://i.imgur.com/CfmOJIz.png * Details of the Series A Preferred - https://i.imgur.com/mngg9pD.png * Dividend rights of above - https://i.imgur.com/tdXFVHV.png It does look like a sweetheart deal where Ascension made a killing. At the very least there seems to be a conflict of interest? The preferred shares are cumulative 8% shares. That means they are guaranteed to be paid 8% in perpetuity. And once these were all converted, the total fair value of the conversion was $592.3M = cash paid $105M + additional value of converted shares. The part that is a little strange is that they do report it as a hit to net income so short report saying they are hiding the cost does not seem totally right either. As my last image shows. * Calculation of net income to common shareholders - https://i.imgur.com/ctyq2Pw.png The dilution to shareholders is quite severe so the cost is real: https://ycharts.com/companies/RCM/shares_outstanding However, this is all in the past and it seems lots of new management in 2022 and CEO, CCO, CFO, CSO all got thrown out. The board does seem stuffed with customers of RCM. I think it is a watch and see what happens situation for me currently.

infobotnews

I've also been keeping an eye on the uranium sector. Think you're spot on about China's push into nuclear energy, and there's a good chance we'll see similar trends in other countries, including the US. As for specific stocks and ETFs, it’s worth looking at a few interesting developments: **AuKing Mining Ltd**: They've just secured three new prospecting licences in Tanzania, bolstering their position in a region that's becoming a hotbed for uranium. This could be a promising sign for the company’s future prospects. **Purepoint Uranium Group Inc**. (PTU): They announced a non-brokered private placement of up to 47 million units. This move could inject some much-needed capital for exploration, but it’s a bit of a wait-and-see situation regarding how it’ll affect their stock value. **Cameco Corp** (CCO): Keep an eye on this one, especially considering the political situation in Niger. Any disruptions in Niger could impact global supply, and since Cameco is a major player, they might feel some of those effects. In terms of ETFs, you might want to check out some that specifically focus on uranium or nuclear energy. These can offer more diversified exposure to the industry without the need to bet on individual stocks.

Previous-Display-593

I keep DCA into CCO. Long holding here! (disclaimer: I dont know what I am doing).

dongliang007

holding CCO.TSX since $20 something... a long time. will keep it.

Superb-Ad-9852

Cameco (TSX CCO). They've ridden the uranium price run and seemingly have peeked but there's so much new nuclear power being announced right now and will continue to be for several years ahead, I think it still has miles to go.

Previous-Display-593

None. I once read a comment the CCO is just so large you might as well just buy it for your Uranium exposure. Not sure how sound that advice is, but I took it and it worked out.

WavemanKnows

Uranium bullish 2024-2025… take a look on CCJ (CCO)

Mrknowitall666

Meh. 6 one way, half a dozen the other. And, you can do bot simultaneously Firms are required to have a CCO and to record written complaints and deal with them. (not so with verbal requests). Finras first stop is going to be to go to the firms cco to inform them of the complaint and ask that it be resolved. FINRA puts the sro in self regulated

JizzStormRedux

Seems like yall get the 3rd degree. How are you defining compliance officer? Like the actual CCO or anyone on the level of partner or higher? The firm I have been involved on has a very detailed compliance structure, and anyone not client facing had almost no restrictions because of how hard they were silo'd from everyone else. Seperate building, seperate everything.

Gahan1772

Cameco. Nothing gave me gains similar to CCO yet.

StockScreener777

💰💰💰Get new daily runners and watchlist in our app! #afterhours #postmarket #watchlist 07/26 $MNK $GENQ $LIXT $ALGN $CCO $CTCX $FBL $SPOK $POAI $AIM https://preview.redd.it/7mnsqbyvsdeb1.jpeg?width=576&format=pjpg&auto=webp&s=d225ebfc7b8b451a713e11238a5658c328994071

StockScreener777

💰💰💰Get new daily runners and watchlist in our app! #afterhours #postmarket #watchlist 07/26 $MNK $GENQ $LIXT $ALGN $CCO $CTCX $FBL $SPOK $POAI $AIM https://preview.redd.it/om9c4ytssdeb1.jpeg?width=576&format=pjpg&auto=webp&s=032434cdaf6c8cfade4a9eb7a4d34429e6c84fb6

69GanjaGuy69

NYSE: CCJ TSX: CCO is breaking out

goodreadKB

It's gonna be a long haul with ups and downs but worth it on MVIS. There will be more ups than downs. CCO is another one, it's a very slow ride but is slowing rising in the past couple of weeks. Cheap stock now so I'll ride it out.

1600hazenstreet

I'll take CCO. Chief Clown Officer, and also would like to explore option of chief of risk management.

spotpea

The CCO I worked for at Bear turned down a job at WaMu to go to MF Global after we crashed. (She was at Lehman before Bear but not sure that counts. She was also fucking amazing.)

Slight_Undertanty

Ahh dad is looking at CCO on the TSE &#x200B; https://www.google.com/search?q=CCO+TSE&rlz=1C1GCEJ\_enUS975US975&oq=CCO+TSE&aqs=chrome..69i57j0i131i433i512j0i20i263i512l2j0i512l3j0i22i30l3.1587j1j7&sourceid=chrome&ie=UTF-8

Mbanks2169

CCO went from $3.39 to $1.05 in 2022

Slight_Undertanty

I show CCO (TSE) @ 28 CAD in Feb 2022 and 38 CAD this Feb. He is trying to show he can do better than the other funds out there with this methodology, I just don't know how to tell him to prove it. They way he tracks it is a mess because he doesn't even use excel...

Ayahuasca-Dreamin

Realized some $DMTK gains today and loaded up on $IDEX at a 52 week low. New COO and CCO in management as well as a new partnership with Mahle.